𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Bupropion for fatigue and as a tumor necrosis factor-α lowering agent in primary biliary cirrhosis

✍ Scribed by Eric Lewin Altschuler; Richard E. Kast


Book ID
116742039
Publisher
Elsevier Science
Year
2005
Tongue
English
Weight
134 KB
Volume
64
Category
Article
ISSN
0306-9877

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Outcomes after switching from one anti–t
✍ Kimme L. Hyrich; Mark Lunt; Kath D. Watson; Deborah P. M. Symmons; Alan J. Silma 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB 👁 1 views

## Abstract ## Objective Patients with rheumatoid arthritis (RA) who experience treatment failure with one anti–tumor necrosis factor (anti‐TNF) agent, due to either inefficacy or toxicity, are frequently switched to a second anti‐TNF agent, although the benefits of switching are unknown. The pres

Carriage of a tumor necrosis factor poly
✍ Brian D. Juran; Elizabeth J. Atkinson; Joseph J. Larson; Erik M. Schlicht; Xiang 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 180 KB

Common genetic variants significantly influence complex diseases such as primary biliary cirrhosis (PBC). We recently reported an association between PBC and a single nucleotide polymorphism (rs231725) of the immunoreceptor gene cytotoxic T-lymphocyte antigen 4 (CTLA4). We hypothesized that PBC risk

Increased nitric oxide synthase activity
✍ I Kurose; S Miura; H Higuchi; N Watanabe; Y Kamegaya; M Takaishi; K Tomita; D Fu 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 311 KB 👁 1 views

## membrane barrier function in the late phase. (HEPATOL-Kupffer cells have been implicated in playing an im- OGY 1996;24:1185-1192.) portant role in the pathogenesis of endotoxemia-associated liver injury. The present study was designed to investigate whether Kupffer cell-derived mediators alter